But, many research studies have shown that certain risk factors that may increase the possibility of cancer are excessive exposure to the chemicals, development of obesity, family history of cancer, and poor lifestyle.
The oncology drug market is enormously growing from past years and is expected to value at $178 billion by 2023.
After this much growth, pharmaceutical companies still face many challenges such as patient enrollment and retention in cancer-research studies, early patient expiration, high cost of cancer-research, and high treatment demand in cancer drug development.
But, patient enrollment and retention in clinical studies are the biggest challenges for the pharmaceutical companies and their clinical researchers to develop new treatment or diagnostic methods.
This is obvious because the patient pool for certain cancers is very less and above that, cancer studies require long follow-up periods for successful completion.
On the other hand, due to limited patient retention, it becomes tough for doctors to retain all patients for a long time, which lead to studying failure or termination.
Clinical Trial Management System Market OverviewClinical Trial Management System Market is mostly a software system which helps to plan, prepare, and manage a large amount of clinical trials data that is produced by biotechnological and pharmaceutical companies.
Drug research has gained momentum in the past few years.
It has led to the need for a standard platform for the management of data and results.Rising prevalence of chronic diseases such as cancer, diabetes, etc.
has led to a drastic rise in the demand for effective drugs and treatments.
However, the implementation of stricter regulations, coupled with the rising rate of clinical trials failure is anticipated to undermine market growth in the years to come.Competitive AnalysisThese players are poised to devise growth strategies that are expected to lead the growth trajectory of the global market over the next couple of years.
Some of the growth strategies opted by the market participants are mergers & acquisitions, partnerships, collaborations, product portfolio development, and technological innovation, among others.eClinForce Inc.Forte Research Systems Inc.OracleiWeb TechnologiesMedidata SolutionsPAREXELBio-OptronicsBioclinicaand IBMThese are some of the key vendors contributing to the development of the global clinical trial management system market.Request FREE Sample of this Report @ https://www.marketresearchfuture.com/sample_request/2054Market SegmentationThe global clinical trial management system market research has been segmented on the basis of type, delivery model, component, and end-user.On the basis of type, the market has been classified as an enterprise clinical trial management system and site clinical trial management system.On the basis of delivery model, the market has been classified as web-based (Hosted CTMS), licensed enterprise and cloud-based CTMS.On the basis of component, the market has been classified as software and service.On the basis of end-user, the market has been classified as medical device manufacturers, pharmaceutical and biopharmaceutical companies, contract research organizations, and others.On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.Regional AnalysisOn the basis of region, the study of the global clinical trial management system market spans across four regions – Asia Pacific, the Middle East & Africa (MEA), Europe, and Americas.Americas is set to dictate the growth pattern of the global market over the next couple of years owing to the presence of robust healthcare IT industry.
